tooluniverse-multiomic-disease-characterization

Characterize diseases across genomics, transcriptomics, proteomics, and pathway layers using ToolUniverse databases.

1.7k|254|Updated Mar 3, 2025
One-click install
npx skills add https://github.com/mims-harvard/ToolUniverse --skill tooluniverse-multiomic-disease-characterization
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: tooluniverse-multiomic-disease-characterization
Source: https://github.com/mims-harvard/ToolUniverse/tree/main/plugins/tooluniverse/skills/tooluniverse-multiomic-disease-characterization
Command: npx skills add https://github.com/mims-harvard/ToolUniverse --skill tooluniverse-multiomic-disease-characterization

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

Understanding a disease requires integrating evidence scattered across genomics, transcriptomics, proteomics, and pathway databases, which is slow and error-prone when done manually. This Skill runs a structured 9-phase pipeline that disambiguates the disease, queries each omics layer through ToolUniverse tools, and produces a cited, scored multi-omics report.

Core Features & Use Cases

  • Layer-by-layer omics analysis: Systematically covers GWAS/ClinVar genomics, GTEx/HPA transcriptomics, STRING/IntAct proteomics, and Reactome/KEGG/GO pathway enrichment.
  • Cross-layer integration: Identifies multi-omics hub genes, grades evidence T1-T4, and computes a 0-100 Multi-Omics Confidence Score.
  • Therapeutic and biomarker discovery: Maps approved drugs, druggable targets, clinical trials, and diagnostic/prognostic biomarker candidates.
  • Use Case: Ask for a multi-omics characterization of Alzheimer's disease and receive a full report with top hub genes, enriched pathways, drug repurposing candidates, and mechanistic hypotheses, each with source citations.

Quick Start

Ask the agent to characterize a disease such as Alzheimer's disease across all omics layers and generate the full multi-omics report.

Frequently Asked Questions about tooluniverse-multiomic-disease-characterization

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I run a multi-omics disease characterization?

Provide a disease name, OMIM ID, EFO ID, or MONDO ID and the pipeline runs 9 phases from disease disambiguation through report finalization. You can optionally specify a tissue of interest or focus on specific omics layers such as genomics or pathways.

What databases does multi-omics disease analysis query?

It queries OpenTargets, GWAS Catalog, ClinVar, gnomAD, GTEx, Human Protein Atlas, Expression Atlas, STRING, IntAct, HumanBase, Reactome, KEGG, WikiPathways, Enrichr, QuickGO, DGIdb, and ClinicalTrials.gov through ToolUniverse tools.

How is the Multi-Omics Confidence Score calculated?

The score sums up to 100 points across data availability per omics layer (40 points), cross-layer evidence concordance (40 points), and evidence quality such as GWAS significance and approved drugs (20 points). Scores of 80-100 indicate comprehensive coverage.

When should I not use multi-omics disease characterization?

Use other skills for single gene or target validation, drug safety profiling, variant interpretation, GWAS-specific analysis, or pathway-only enrichment. This skill is intended for integrated cross-layer disease deep-dives, not single-layer questions.

What happens if a disease has limited omics data?

For rare or monogenic diseases the pipeline falls back to ClinVar variants, OpenTargets genetic evidence, and individual gene expression lookups. Missing layers are marked as no data available and the confidence score is adjusted downward accordingly.